During the past decade, Clinical Research Facility, Queen Elizabeth University Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 9 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Facility, Queen Elizabeth University Hospital" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 8 trials, followed by "NHS Greater Glasgow and Clyde" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Facility, Queen Elizabeth University Hospital" #1 collaborator was "University of Glasgow" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Biotechnology and Biological Sciences Research Council" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator and "CHDI Foundation, Inc." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Facility, Queen Elizabeth University Hospital" are "Cystic Fibrosis" (9 trials), "Crohn's Disease" (2 trials), "Hypertension" (2 trials), "Migraine" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Clinical Research Facility, Queen Elizabeth University Hospital" in a lesser frequency.

Most popular intervention types in "Clinical Research Facility, Queen Elizabeth University Hospital" are "Drug" (24 trials), "Device" (2 trials), "Dietary Supplement" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "IVA" (8 trials), "ELX/TEZ/IVA" (6 trials), "Filgotinib" (4 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Facility, Queen Elizabeth University Hospital" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research Facility, Queen Elizabeth University Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Clinical Research Facility, Queen Elizabeth University Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Facility, Queen Elizabeth University Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".